CDNA Q3 2017 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$882M

Q3 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$12M-2.3% YoY

Gross Profit

$7M57.3% margin

Operating Income

-$4M-31.7% margin

Net Income

-$14M-117.0% margin

EPS (Diluted)

$-0.63

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$430,000

Balance Sheet

Total Assets

$75M

Total Liabilities

$75M

Stockholders' Equity

-$311,000

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$12M	-2.3%
Gross Profit	$7M	$7M	+7.2%
Operating Income	-$4M	-$5M	+21.7%
Net Income	-$14M	-$4M	-279.1%

Revenue Segments

Care Dx

$8M68%

Olerup

$4M32%

Geographic Segments

North America

$9M77%

E M E A

$3M21%

AUSTRALIA

$125,0001%

Latin America

$104,0001%